Aqua Bio Technology ASA has entered into an agreement with ScandiDerma for the distribution and sales of the Cuvget product family. The collaboration with ScandiDerma is ABT's first step in implementing the Company's expanded business model as announced on 11 January 2017. ABT has secured exclusive distribution rights for Europe, the Middle East and Africa (EMEA), and will in the initial phase focus on the Scandinavian markets. The first product, Cuvget Instant Vitamine Ampoules, will be launched immediately with additional three products to follow in the coming months. The agreement gives ABT an option to acquire all shares in ScandiDerma AS at pre-agreed terms. The option expires on 31 December 2017. Based on performance in 2017, ABT will decide whether to utilize the option or to continue the collaboration on commercial terms beyond 2017.